133 related articles for article (PubMed ID: 33047878)
1. Exploring the components of bleeding outcomes in transfusion trials for patients with hematologic malignancy.
Balitsky AK; Liu Y; Van der Meer PF; Heddle NM; Arnold DM
Transfusion; 2021 Jan; 61(1):286-293. PubMed ID: 33047878
[TBL] [Abstract][Full Text] [Related]
2. Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions.
Stanworth SJ; Dyer C; Choo L; Bakrania L; Copplestone A; Llewelyn C; Norfolk D; Powter G; Littlewood T; Wood EM; Murphy MF;
Transfus Med Rev; 2010 Jul; 24(3):163-71. PubMed ID: 20656185
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
[TBL] [Abstract][Full Text] [Related]
4. Feasibility and usefulness of self-assessment of bleeding in patients with haematological malignancies, and the association between platelet count and bleeding.
Stanworth SJ; Dyer C; Casbard A; Murphy MF
Vox Sang; 2006 Jul; 91(1):63-9. PubMed ID: 16756603
[TBL] [Abstract][Full Text] [Related]
5. Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
Antun AG; Gleason S; Arellano M; Langston AA; McLemore ML; Gaddh M; el Rassi F; Bernal-Mizrachi L; Galipeau J; Heffner LT; Winton EF; Khoury HJ
Cancer; 2013 Nov; 119(21):3784-7. PubMed ID: 23921838
[TBL] [Abstract][Full Text] [Related]
6. Benefits of Thromboelastography and Thrombin Generation Assay for Bleeding Prediction in Patients With Thrombocytopenia or Hematologic Malignancies.
Kim SY; Gu JY; Yoo HJ; Kim JE; Jang S; Choe S; Koh Y; Kim I; Kim HK
Ann Lab Med; 2017 Nov; 37(6):484-493. PubMed ID: 28840985
[TBL] [Abstract][Full Text] [Related]
7. Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis.
Stanworth SJ; Hudson CL; Estcourt LJ; Johnson RJ; Wood EM;
Haematologica; 2015 Jun; 100(6):740-7. PubMed ID: 25795717
[TBL] [Abstract][Full Text] [Related]
8. Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial.
Stanworth SJ; Estcourt LJ; Llewelyn CA; Murphy MF; Wood EM;
Transfusion; 2014 Oct; 54(10):2385-93. PubMed ID: 24724863
[TBL] [Abstract][Full Text] [Related]
9. The observation of bleeding complications in haemato-oncological patients: stringent watching, relevant reporting.
Ypma PF; Kerkhoffs JL; van Hilten JA; Middelburg RA; Coccoris M; Zwaginga JJ; Beckers EM; Fijnheer R; van der Meer PF; Brand A
Transfus Med; 2012 Dec; 22(6):426-31. PubMed ID: 23036067
[TBL] [Abstract][Full Text] [Related]
10. Platelet transfusions in haematologic malignancies in the last six months of life.
Moracchini J; Seigeot A; Angelot-Delettre F; Vienot A; Aubry R; Daguindau É; Deconinck E; Frache S; Tiberghien P
Vox Sang; 2021 Apr; 116(4):425-433. PubMed ID: 32790960
[TBL] [Abstract][Full Text] [Related]
11. Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study.
Estcourt LJ; Stanworth SJ; Harrison P; Powter G; McClure M; Murphy MF; Mumford AD
Br J Haematol; 2014 Aug; 166(4):581-91. PubMed ID: 24797282
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia.
Heddle NM; Cook RJ; Tinmouth A; Kouroukis CT; Hervig T; Klapper E; Brandwein JM; Szczepiorkowski ZM; AuBuchon JP; Barty RL; Lee KA;
Blood; 2009 Feb; 113(7):1564-73. PubMed ID: 19109560
[TBL] [Abstract][Full Text] [Related]
13. Thromboelastography may predict risk of grade 2 bleeding in thrombocytopenic patients.
Opheim EN; Apelseth TO; Stanworth SJ; Eide GE; Hervig T
Vox Sang; 2017 Aug; 112(6):578-585. PubMed ID: 28639693
[TBL] [Abstract][Full Text] [Related]
14. Expected individual benefit of prophylactic platelet transfusions in hemato-oncology patients based on bleeding risks.
Cornelissen LL; Caram-Deelder C; Fustolo-Gunnink SF; Groenwold RHH; Stanworth SJ; Zwaginga JJ; van der Bom JG
Transfusion; 2021 Sep; 61(9):2578-2587. PubMed ID: 34263930
[TBL] [Abstract][Full Text] [Related]
15. Factors determining the risk of severe (WHO grades 3 and 4) hemorrhage in hematologic patients.
Drozd-Sokolowska JE; Wiktor-Jedrzejczak W
Transfus Apher Sci; 2011 Apr; 44(2):129-34. PubMed ID: 21334260
[TBL] [Abstract][Full Text] [Related]
16. Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?
Stanworth SJ; Hyde C; Brunskill S; Murphy MF
Br J Haematol; 2005 Dec; 131(5):588-95. PubMed ID: 16351634
[TBL] [Abstract][Full Text] [Related]
17. Bleeding frequency and characteristics among hematologic malignancy inpatient rehabilitation patients with severe thrombocytopenia.
Fu JB; Tennison JM; Rutzen-Lopez IM; Silver JK; Morishita S; Dibaj SS; Bruera E
Support Care Cancer; 2018 Sep; 26(9):3135-3141. PubMed ID: 29594490
[TBL] [Abstract][Full Text] [Related]
18. New strategies for the optimal use of platelet transfusions.
Blajchman MA; Slichter SJ; Heddle NM; Murphy MF
Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082
[TBL] [Abstract][Full Text] [Related]
19. Patients treated for acute VTE during periods of treatment-related thrombocytopenia have high rates of recurrent thrombosis and transfusion-related adverse outcomes.
Samuelson Bannow BT; Walter RB; Gernsheimer TB; Garcia DA
J Thromb Thrombolysis; 2017 Nov; 44(4):442-447. PubMed ID: 28884390
[TBL] [Abstract][Full Text] [Related]
20. Pathogen-reduced platelets for the prevention of bleeding.
Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
